A thrombocytosis occurring in Philadelphia positive CML in molecular response to imatinib can reveal an underlying JAK2(V617F) myeloproliferative neoplasm.
暂无分享，去创建一个
O. Tournilhac | M. Berger | C. Chaleteix | A. Tchirkov | P. Vago | L. Gouas | C. Goumy | L. Véronèse | C. Richard-Pebrel | A. Ledoux-Pilon | J. Fleury | J. Bay